MedTrace Logo

Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo.

NCT07174648 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-03-27

No results posted yet for this study

Summary

This study is being done to learn more about the disease in Ituri and to evaluate a new rapid test that may help doctors find the disease more quickly. This research includes characterisation of clinical presentations and pathology of plague, as well as identification of circumstances that may increase the risk of infection. Biological samples collected include blood, mouth swab, saliva, a bubo aspirate and a sputum sample (the latter only in case of plague in the lungs). These samples will be used to test the performance of the new rapid study test.

Conditions

  • Plague
  • Bubonic; Plague, Skin
  • Plague, Pneumonic

Sponsors & Collaborators

  • Institut Pasteur

    collaborator INDUSTRY

  • Université Paris-Saclay

    collaborator OTHER

  • Centre de Recherche en Maladies Tropicales de L'Ituri (CRMT)

    collaborator UNKNOWN

  • Institut National pour la Recherche Biomedicale (INRB)

    collaborator UNKNOWN

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Principal Investigators

  • Laurens Liesenborghs · Institute of Tropical Medicine, Antwerp, Belgium

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2029-01-02
Completion
2029-01-02

Countries

  • Democratic Republic of the Congo

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07174648 on ClinicalTrials.gov